Treatment of therapy-refractory B-lineage acute lymphoblastic leukemia with an apoptosis-inducing CD19-directed tyrosine kinase inhibitor.

Source:http://linkedlifedata.com/resource/pubmed/id/10632319

Download in:

View as

General Info

PMID
10632319